Patent details

EP3583947 Title: STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDES AND CONJUGATES THEREOF

Basic Information

Publication number:
EP3583947
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP191795772
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDES AND CONJUGATES THEREOF
French Title of Invention:
POLYSACCHARIDES CAPSULAIRES DE STREPTOCOCCUS PNEUMONIAE ET LEURS CONJUGUÉS
German Title of Invention:
KAPSULARE POLYSACCHARIDE AUS STREPTOCOCCUS PNEUMONIAE UND KONJUGATE DAVON
SPC Number:

Dates

Filing date:
15/01/2015
Grant date:
11/10/2023
EP Publication Date:
25/12/2019
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
11/10/2023
EP B1 Publication Date:
11/10/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
15/01/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
04/10/2023
 
 

Name:
Pfizer Inc.
Address:
66 Hudson Boulevard East, New York, NY 10001-2192, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
16/10/2023
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
HAN, Mingming
Address:
United States (US)

2

Name:
COOPER, David
Address:
United States (US)

3

Name:
PRASAD, Avvari Krishna
Address:
United States (US)

4

Name:
WATSON, Wendy Jo
Address:
United States (US)

Priority

Priority Number:
201461929561 P
Priority Date:
21/01/2014
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/09; A61K 39/385; A61K 39/00; A61P 11/00; A61P 31/04;

Publication

European Patent Bulletin

1

Issue number:
202341
Publication date:
11/10/2023
Description:
Grant (B1)

2

Issue number:
202433
Publication date:
14/08/2024
Description:
Opposition procedure started

Annual Fees

Annual Fee Due Date:
02/02/2026
Annual Fee Number:
12
Annual Fee Amount:
165 Euro
Expected Payer:
Last Annual Fee Payment Date:
18/12/2024
Last Annual Fee Paid Number:
11
Last Annual Fee Paid Amount:
148 Euro
Payer:
MASTER DATA CENTER INC (ex Clarivate Analytics)
Filing date Document type Number of pages
16/10/2023 Power Of Attorney 1
17/10/2023 Outgoing Correspondence 1